VisionCare’s implantable miniature telescope is the first FDA approved device designed to improve the vision of late stage age-related macular degeneration patients.
CMS intends to assign the device to the new Ambulatory Payment Classification 0351, Level VII Anterior Segment Eye Procedures. The mean cost would be calculated using claims data. If approved, the new APC will be effective Jan. 1, 2014.
More Articles on Ophthalmology:
Dr. David Risner Joins Heaton Eye Associates in Texas
Geneva Eye Clinic Partners With Foundation Fighting Blindness
AAO Partners With FDA to Streamline Regulatory Process
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.